Stay updated with the latest novartis news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on novartis topics.
Chennai: The WTO's 14th Ministerial Conference (MC14) held in Cameroon ended without agreement on key issues, including e-commerce moratorium and expiry of safeguards against non-violation complaints against intellectual property policies. MC14 was one of the most inconclusive ministerial conferences in recent years. Despite WTO remaining ineffective in mitigating trade uncertainties, India to build coalitions to defend consensus-based decision-making at WTO, which is under threat due to growing ...Read More >
New Delhi [India], September 26 (ANI): European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI). On Friday, U.S. President Donald Trump announced that from October 1, a 100 per cent tariff would be imposed on all imported branded or patented pharmaceutical products, unless ...Read More >
Sept 12 (Reuters) - European shares slipped in choppy trading on Friday, weighed by a drop in healthcare stocks, while investors also braced for Fitch's credit rating verdict on France later in the day. After rising nearly 0.2% earlier in the day, the pan-European STOXX 600 (.STOXX), opens new tab reversed course and was last down 0.2% to 554.8 points, as of 0845 GMT. Healthcare stocks (.SXDP), opens new tab weighed the most, slipping 0.6%. Swiss pharmaceutical company Novartis (NOVN.S), opens ...Read More >
New Delhi: The GST rate cuts announced last week will make medicines used for the treatment of critical conditions like multiple myeloma, lung cancer, blood cancer, lymphoma, Gaucher disease, Pompe disease and haemophilia significantly cheaper and help more patients to avail of treatment, health experts said. A pack of leukaemia drug asciminib 60 (40 mg tablets), which used to cost ₹2,35,000 with GST, will become cheaper by ₹25,000, as per data from market research firm PharmaTrac. Obinutuzu ...Read More >
HÀ NỘI While more than half of people living with rare diseases in Việt Nam are children, access to rare disease treatment remains limited due to high costs and a lack of comprehensive health insurance coverage. According to the Ministry of Health, Việt Nam has about six million people living with rare diseases, 58 per cent of whom are children. Data shows that an alarming 30 per cent of children with rare diseases die before the age of five. Rare diseases often include metabolic disord ...Read More >
NEW DELHI, 20 August 2025: Dr Vinod K Paul, Member (Health), NITI Aayog today stated that rare diseases are estimated to collectively affect close to 90 million Indians, making them both a health and societal challenge. He emphasized that with only a fraction of the 7,000 rare diseases having approved therapies, indigenous manufacturing, stronger registries, and multi‑ministerial coordination must be prioritized. Addressing the National conference on 'Rare Diseases', organized by FICCI, jointly ...Read More >
PRNewswire Mumbai (Maharashtra) [India], August 14: Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare-specialist advertising agencies, has announced the launch of its new hub in Singapore. With over 15 years of experience in solving complex healthcare challenges, Medulla is now looking to create a super-specialist category as the first digital healthcare advertising agency in Asia. New Hub to Deliver Scalable, Specialist Healthcare Marketing Solutions Across APAC. Me ...Read More >
Mumbai (Maharashtra) [India], August 14: Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare-specialist advertising agencies, has announced the launch of its new hub in Singapore. With over 15 years of experience in solving complex healthcare challenges, Medulla is now looking to create a super-specialist category as the first digital healthcare advertising agency in Asia. New Hub to Deliver Scalable, Specialist Healthcare Marketing Solutions Across APAC. Also Read | Ne ...Read More >
New Delhi, Aug 12 (PTI) Drug firm Lupin on Tuesday said it has partnered with Switzerland-based Sandoz Group AG to commercialise its biosimilar ranibizumab across multiple regions. Under the terms of the agreement, Sandoz will oversee commercialisation of the product across the European Union (excluding Germany), Switzerland, Norway, Australia, Hong Kong, Vietnam, and Malaysia, the Mumbai-based drug maker said in a statement. Lupin will be responsible for manufacturing the product and for regu ...Read More >
NEW DELHI: Following the acquisition of JB Chemicals & Pharmaceuticals (JB Chem), Torrent Pharma is set to become India's fifth-largest pharmaceutical company, capturing a 4.6% share of the Rs 2.3 lakh crore organised retail market.The acquisition boosts Torrent Pharma's rank from 7th to 5th place, increasing its market share from 3.6% to 4.6%, according to data gathered by TOI from market intelligence firm Pharmarack.Sun Pharma leads the highly fragmented pharma market with sales of over Rs 19, ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.